RT @ryoma_tanaka: アスピリンについてのスタディーが3つNEJMに発表されましたね。 出血が増えて悪性疾患が増えて心血管疾患は減らなくて、死亡リスクは増えるという何だか大変な結果になっています。 https://t.co/tdsfmj8miC https://t…
"Effect of Aspirin on Cardiovascular Events and Bleeding in the Healthy Elderly" https://t.co/HEAft9IXs6 #mustread #feedly
RT @krychtiukmd: A series of articles in @nejm randomizing "healthy elderly" (>70yrs / n>19.000 /w/o CVD) to aspirin 100mg/d vs. placebo sh…
RT @A_SisoAlmirall: The use of low-dose aspirin as a Primary Prevention strategy in Older adults resulted in a significantly higher risk of…
RT @EricTopol: The results on lack of any cardiovascular benefit but increase in bleeding https://t.co/102822NSxC @NEJM https://t.co/9QhEwY…
RT @ryoma_tanaka: アスピリンについてのスタディーが3つNEJMに発表されましたね。 出血が増えて悪性疾患が増えて心血管疾患は減らなくて、死亡リスクは増えるという何だか大変な結果になっています。 https://t.co/tdsfmj8miC https://t…
RT @ryoma_tanaka: アスピリンについてのスタディーが3つNEJMに発表されましたね。 出血が増えて悪性疾患が増えて心血管疾患は減らなくて、死亡リスクは増えるという何だか大変な結果になっています。 https://t.co/tdsfmj8miC https://t…
RT @ryoma_tanaka: アスピリンについてのスタディーが3つNEJMに発表されましたね。 出血が増えて悪性疾患が増えて心血管疾患は減らなくて、死亡リスクは増えるという何だか大変な結果になっています。 https://t.co/tdsfmj8miC https://t…
When drug companies make billions and patients pay the price. The same goes for hypertension and cholesterol acceptable levels.
RT @ryoma_tanaka: アスピリンについてのスタディーが3つNEJMに発表されましたね。 出血が増えて悪性疾患が増えて心血管疾患は減らなくて、死亡リスクは増えるという何だか大変な結果になっています。 https://t.co/tdsfmj8miC https://t…
RT @monashperiopmed: PeriopMed AOTW: Low-dose aspirin in older adults results in a higher risk of major hemorrhage and no change in risk of…
RT @pauldub67: A pivotal moment in primary prevention ? @mmamas1973 @DrPascalMeier @sbrugaletta @hect2701 @PCRonline @EuroInterventio @Cath…
RT @A_SisoAlmirall: The use of low-dose aspirin as a Primary Prevention strategy in Older adults resulted in a significantly higher risk of…
RT @ryoma_tanaka: アスピリンについてのスタディーが3つNEJMに発表されましたね。 出血が増えて悪性疾患が増えて心血管疾患は減らなくて、死亡リスクは増えるという何だか大変な結果になっています。 https://t.co/tdsfmj8miC https://t…
RT @NEJM: Original Article: Effect of #Aspirin on CV Events and Bleeding in the Healthy Elderly (ASPREE) https://t.co/XPjVR3gDh4 https://t.…
RT @NicAuBlack: Results of the ASPREE trial, led by @MonashUni researchers are out. "The use of low-dose aspirin as a primary prevention st…
RT @krychtiukmd: A series of articles in @nejm randomizing "healthy elderly" (>70yrs / n>19.000 /w/o CVD) to aspirin 100mg/d vs. placebo sh…
RT @jcolladopuerta: Aspirina en ancianos: más sangrados y no menos eventos CV que PCB, @NEJM, https://t.co/uU6jcdqFdB #elderly #cardiovascu…
RT @doctormacias: En ancianos sanos, la aspirina NO reduce los infartos y embolias, y SÍ aumenta el riesgo de hemorragias. https://t.co/oP…
RT @ryoma_tanaka: アスピリンについてのスタディーが3つNEJMに発表されましたね。 出血が増えて悪性疾患が増えて心血管疾患は減らなくて、死亡リスクは増えるという何だか大変な結果になっています。 https://t.co/tdsfmj8miC https://t…
Aspirina en ancianos: más sangrados y no menos eventos CV que PCB, @NEJM, https://t.co/uU6jcdqFdB #elderly #cardiovascular #prevention
RT @sean9n: Aspirin for primary prevention in older people? Just say no. Important to actively stop this drug https://t.co/Dpl1pr5rnG
RT @NEJM: Original Article: Effect of #Aspirin on CV Events and Bleeding in the Healthy Elderly (ASPREE) https://t.co/XPjVR3gDh4 https://t.…
RT @turkerkilic: #Aspirin ’in Kalp-Damar Hastalıklarının önlenmesinde kullanılmasında *yararsız* olduğuna dair iki önemli çalışma yayınland…
(ii) Primary #prevention with 100 mg #Asirin does *not* decrease #cardiovascular disease but rather promotes #hemorrhage. #CVD #ASPREE https://t.co/B34xdEwGPV https://t.co/B34xdEwGPV
RT @alebura: Effect of Aspirin on Cardiovascular Events and Bleeding in the Healthy Elderly | NEJM https://t.co/ZWwbavOGni
…川崎病には使えるんか…?
RT @doctormacias: En ancianos sanos, la aspirina NO reduce los infartos y embolias, y SÍ aumenta el riesgo de hemorragias. https://t.co/oP…
RT @doctormacias: En ancianos sanos, la aspirina NO reduce los infartos y embolias, y SÍ aumenta el riesgo de hemorragias. https://t.co/oP…
RT @DrAhmedKalebi: “The use of low-dose aspirin as a primary prevention strategy in older adults resulted in a significantly higher risk of…
RT @NEJM: Original Article: Effect of #Aspirin on CV Events and Bleeding in the Healthy Elderly (ASPREE) https://t.co/XPjVR3gDh4 https://t.…
RT @turkerkilic: #Aspirin ’in Kalp-Damar Hastalıklarının önlenmesinde kullanılmasında *yararsız* olduğuna dair iki önemli çalışma yayınland…
RT @monashperiopmed: PeriopMed AOTW: Low-dose aspirin in older adults results in a higher risk of major hemorrhage and no change in risk of…
Pretty clear message, at least for 100mg of aspirin in those over 70y seeking primary prevention: ‘Just say no’ https://t.co/dkbkLSJghv
RT @NEJM: Original Article: Effect of #Aspirin on CV Events and Bleeding in the Healthy Elderly (ASPREE) https://t.co/XPjVR3gDh4 https://t.…
RT @Office_j: 【米国、豪州、高齢者19114名ランダム化、4.7年観察 ”ASPREE”:アスピリン100mg/日で、大出血発生率は8.6/1000例・年。対プラセボ [6.2/1000例・年] HRは1.38 [95%CI 1.18-1.62]。CVイベントは1…
RT @doctormacias: En ancianos sanos, la aspirina NO reduce los infartos y embolias, y SÍ aumenta el riesgo de hemorragias. https://t.co/oP…
RT @TJaredBunch: OTC ASA is so commonly used and marketed in the elderly as a “healthy” choice, data continues to show no benefit https:/…
La aspirina como protectora cardiovascular. ¿Un mito que se tambalea? Effect of Aspirin on Cardiovascular Events and Bleeding in the Healthy Elderly | NEJM https://t.co/38nkAgEoun
RT @ryoma_tanaka: アスピリンについてのスタディーが3つNEJMに発表されましたね。 出血が増えて悪性疾患が増えて心血管疾患は減らなくて、死亡リスクは増えるという何だか大変な結果になっています。 https://t.co/tdsfmj8miC https://t…
RT @ValleAlfonso: Low-dose aspirin as a primary prevention strategy in older adults ⤴️ risk of major hemorrhage and did ⛔️not result in a s…
RT @NEJM: Original Article: Effect of #Aspirin on CV Events and Bleeding in the Healthy Elderly (ASPREE) https://t.co/XPjVR3gDh4 https://t.…
RT @krychtiukmd: A series of articles in @nejm randomizing "healthy elderly" (>70yrs / n>19.000 /w/o CVD) to aspirin 100mg/d vs. placebo sh…
RT @doctormacias: En ancianos sanos, la aspirina NO reduce los infartos y embolias, y SÍ aumenta el riesgo de hemorragias. https://t.co/oP…
RT @NEJM: Original Article: Effect of #Aspirin on CV Events and Bleeding in the Healthy Elderly (ASPREE) https://t.co/XPjVR3gDh4 https://t.…
RT @Ramipril_: Prevención sin límites. El ácido acetilsalicílico en dosis bajas, como estrategia de prevención primaria en ancianos no esta…
RT @Sandroppa: And so it begins. Had to field calls today from relatives to interpret these results after media reports scared the life out…
RT @alebura: Effect of Aspirin on Cardiovascular Events and Bleeding in the Healthy Elderly | NEJM https://t.co/ZWwbavOGni
RT @turkerkilic: #Aspirin ’in Kalp-Damar Hastalıklarının önlenmesinde kullanılmasında *yararsız* olduğuna dair iki önemli çalışma yayınland…
RT @NEJM: Original Article: Effect of #Aspirin on CV Events and Bleeding in the Healthy Elderly (ASPREE) https://t.co/XPjVR3gDh4 https://t.…
RT @CMichaelGibson: In primary prevention in elderly patients, Aspirin does not reduce Cardiovascular Events and increases Bleeding in the…
RT @CMichaelGibson: In primary prevention in elderly patients, Aspirin does not reduce Cardiovascular Events and increases Bleeding in the…
RT @krychtiukmd: A series of articles in @nejm randomizing "healthy elderly" (>70yrs / n>19.000 /w/o CVD) to aspirin 100mg/d vs. placebo sh…
RT @ErinMichos: This null result was for CV events, similar to #ARRIVE. In #ASPREE, a primary prevention RCT of older adults free of known…
RT @NEJM: Original Article: Effect of #Aspirin on CV Events and Bleeding in the Healthy Elderly (ASPREE) https://t.co/XPjVR3gDh4 https://t.…
RT @doctormacias: En ancianos sanos, la aspirina NO reduce los infartos y embolias, y SÍ aumenta el riesgo de hemorragias. https://t.co/oP…
RT @EricTopol: The results on lack of any cardiovascular benefit but increase in bleeding https://t.co/102822NSxC @NEJM https://t.co/9QhEwY…
RT @doctormacias: En ancianos sanos, la aspirina NO reduce los infartos y embolias, y SÍ aumenta el riesgo de hemorragias. https://t.co/oP…
RT @HPEducatorPH: Study via @NEJM: The use of low-dose aspirin as a primary prevention strategy in older adults resulted in a significantly higher risk of major hemorrhage and did not result in a significantly lower risk of cardiovascular disease than pl…
RT @krychtiukmd: A series of articles in @nejm randomizing "healthy elderly" (>70yrs / n>19.000 /w/o CVD) to aspirin 100mg/d vs. placebo sh…
RT @CMichaelGibson: In primary prevention in elderly patients, Aspirin does not reduce Cardiovascular Events and increases Bleeding in the…
RT @krychtiukmd: A series of articles in @nejm randomizing "healthy elderly" (>70yrs / n>19.000 /w/o CVD) to aspirin 100mg/d vs. placebo sh…
RT @turkerkilic: #Aspirin ’in Kalp-Damar Hastalıklarının önlenmesinde kullanılmasında *yararsız* olduğuna dair iki önemli çalışma yayınland…
RT @krychtiukmd: A series of articles in @nejm randomizing "healthy elderly" (>70yrs / n>19.000 /w/o CVD) to aspirin 100mg/d vs. placebo sh…
Will this change your practice? Lack of effect of aspirin for primary prevention in older people. https://t.co/o4pzH3CeIN
RT @NicAuBlack: Results of the ASPREE trial, led by @MonashUni researchers are out. "The use of low-dose aspirin as a primary prevention st…
RT @ryoma_tanaka: アスピリンについてのスタディーが3つNEJMに発表されましたね。 出血が増えて悪性疾患が増えて心血管疾患は減らなくて、死亡リスクは増えるという何だか大変な結果になっています。 https://t.co/tdsfmj8miC https://t…
RT @krychtiukmd: A series of articles in @nejm randomizing "healthy elderly" (>70yrs / n>19.000 /w/o CVD) to aspirin 100mg/d vs. placebo sh…
RT @CMichaelGibson: In primary prevention in elderly patients, Aspirin does not reduce Cardiovascular Events and increases Bleeding in the…
RT @CMichaelGibson: In primary prevention in elderly patients, Aspirin does not reduce Cardiovascular Events and increases Bleeding in the…
RT @doctormacias: En ancianos sanos, la aspirina NO reduce los infartos y embolias, y SÍ aumenta el riesgo de hemorragias. https://t.co/oP…
And so it begins. Had to field calls today from relatives to interpret these results after media reports scared the life out of them. Similar to the reports on CaD on falls/fx these data relevant to low-risk healthy older people. People - continue to follo
RT @CMichaelGibson: In primary prevention in elderly patients, Aspirin does not reduce Cardiovascular Events and increases Bleeding in the…
RT @turkerkilic: #Aspirin ’in Kalp-Damar Hastalıklarının önlenmesinde kullanılmasında *yararsız* olduğuna dair iki önemli çalışma yayınland…
RT @monashperiopmed: PeriopMed AOTW: Low-dose aspirin in older adults results in a higher risk of major hemorrhage and no change in risk of…
low-dose aspirin in older adults resulted in a higher risk of major hemorrhage and did not result in a significantly lower risk of cardiovascular disease https://t.co/bshbHOlmFN
PeriopMed AOTW: Low-dose aspirin in older adults results in a higher risk of major hemorrhage and no change in risk of cardiovascular disease. Amazing and important achievement by John McNeil and ASPREE group. @CCSMonash
Important study arguing against aspirin use for primary prevention in older adults. https://t.co/bBxLR5pIhN
RT @CMichaelGibson: In primary prevention in elderly patients, Aspirin does not reduce Cardiovascular Events and increases Bleeding in the…
RT @CMichaelGibson: In primary prevention in elderly patients, Aspirin does not reduce Cardiovascular Events and increases Bleeding in the…
RT @doctormacias: En ancianos sanos, la aspirina NO reduce los infartos y embolias, y SÍ aumenta el riesgo de hemorragias. https://t.co/oP…
RT @Bloodman: Another trial showing no role for ASA in primary prevention in the current era of statins and other risk factor reduction htt…
RT @turkerkilic: #Aspirin ’in Kalp-Damar Hastalıklarının önlenmesinde kullanılmasında *yararsız* olduğuna dair iki önemli çalışma yayınland…
NEJM「健康高齢者における心血管イベントと出血へのアスピリンの効果」 https://t.co/0GaELg2vXp 同じ試験の心血管イベントと出血に絞った解析。やはり否定的な結果。
RT @ryoma_tanaka: アスピリンについてのスタディーが3つNEJMに発表されましたね。 出血が増えて悪性疾患が増えて心血管疾患は減らなくて、死亡リスクは増えるという何だか大変な結果になっています。 https://t.co/tdsfmj8miC https://t…
RT @CMichaelGibson: In primary prevention in elderly patients, Aspirin does not reduce Cardiovascular Events and increases Bleeding in the…
RT @CMichaelGibson: In primary prevention in elderly patients, Aspirin does not reduce Cardiovascular Events and increases Bleeding in the…
RT @turkerkilic: #Aspirin ’in Kalp-Damar Hastalıklarının önlenmesinde kullanılmasında *yararsız* olduğuna dair iki önemli çalışma yayınland…
RT @doctormacias: En ancianos sanos, la aspirina NO reduce los infartos y embolias, y SÍ aumenta el riesgo de hemorragias. https://t.co/oP…
RT @doctormacias: En ancianos sanos, la aspirina NO reduce los infartos y embolias, y SÍ aumenta el riesgo de hemorragias. https://t.co/oP…
Study via @NEJM: The use of low-dose aspirin as a primary prevention strategy in older adults resulted in a significantly higher risk of major hemorrhage and did not result in a significantly lower risk of cardiovascular disease than placebo. #HeartHealth
RT @CMichaelGibson: In primary prevention in elderly patients, Aspirin does not reduce Cardiovascular Events and increases Bleeding in the…
RT @fcanestro: ¿ Que os parece si esta semana le dedicamos un ratito a revisar a los mayores de 70 años sanos que tienen en su tratamiento…
Effect of Aspirin on Cardiovascular Events and Bleeding in the Healthy Elderly | NEJM https://t.co/PfxyaOouyl
Effect of Aspirin on Cardiovascular Events and Bleeding in the Healthy Elderly | NEJM https://t.co/8T0pFZ1UQI
RT @ryoma_tanaka: アスピリンについてのスタディーが3つNEJMに発表されましたね。 出血が増えて悪性疾患が増えて心血管疾患は減らなくて、死亡リスクは増えるという何だか大変な結果になっています。 https://t.co/tdsfmj8miC https://t…
RT @NEJM: Original Article: Effect of #Aspirin on CV Events and Bleeding in the Healthy Elderly (ASPREE) https://t.co/XPjVR3gDh4 https://t.…
Although the lack of CV benefit is interesting, I'm also surprised by the high major bleeding risk in both groups. https://t.co/eMJwNdvRDm
RT @CMichaelGibson: In primary prevention in elderly patients, Aspirin does not reduce Cardiovascular Events and increases Bleeding in the…
RT @doctormacias: En ancianos sanos, la aspirina NO reduce los infartos y embolias, y SÍ aumenta el riesgo de hemorragias. https://t.co/oP…